Literature DB >> 33022092

Life under the CABOSUN: Cabozantinib improves quality-adjusted survival in comparison with sunitinib.

Jeanny B Aragon-Ching1, Ravi A Madan2.   

Abstract

Entities:  

Keywords:  kidney cancer; quality of life; renal cell carcinoma; toxicity; tyrosine kinase inhibitors

Mesh:

Substances:

Year:  2020        PMID: 33022092     DOI: 10.1002/cncr.33168

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  1 in total

1.  Balancing efficacy and quality of life measurements among metastatic renal cell carcinoma (RCC) studies.

Authors:  Jeanny B Aragon-Ching
Journal:  Oncoscience       Date:  2021-03-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.